brukinsa
Generic: zanubrutinib
brukinsa: developed by 1 company · 2 FDA decisions. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| BeOne Medicines Ltd. (ONC) | Approved |
FDA Decisions
Frequently asked questions
Who is developing brukinsa?
brukinsa is being developed by BeOne Medicines Ltd..
What is brukinsa's latest FDA decision?
The most recent tracked FDA decision for brukinsa is Approval, dated June 10, 2025.
Get deeper analysis on brukinsa
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis